Popular: Primary Care, Heart Disease, Joint Replacement
Find a Provider

Davood Vafai, MD

There are 15 Clinical Trials currently being conducted by Davood Vafai, MD
Title
Type
Enrollment
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma
Cancer
Open
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Cancer
Closed
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Cancer
Open
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Cancer
Open
CompassHER2: T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial
Cancer
Open
Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study
Cancer
Open
A032101: Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)
Cancer
Closed
Study of Personalized Cancer Therapy to Determine Response and Toxicity. UCSD-HRPP-130794
Cancer
Open
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Cancer
Closed
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Cancer
Open
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
Cancer
Open
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer
Cancer
Closed
Breast Cancer WEight Loss Study (BWEL Study)
Cancer
Closed
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Cancer
Open
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Cancer
Open
Davood Vafai, MD
LIVE

Resources

Key Contacts

  • © 2025 Eisenhower Health · All rights reserved.